These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2472025)

  • 1. Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes.
    Fujii Y; Fujii S; Kaneko T
    Transplantation; 1989 Jun; 47(6):1081-3. PubMed ID: 2472025
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine does not inhibit mitogen-induced inositol phospholipid degradation in mouse lymphocytes.
    Bijsterbosch MK; Klaus GG
    Immunology; 1985 Nov; 56(3):435-40. PubMed ID: 3000926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new immunosuppressive agent, FK506, inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity.
    Yoshimura N; Matsui S; Hamashima T; Lee CJ; Oka T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1045-7. PubMed ID: 2468202
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction.
    Bierer BE; Schreiber SL; Burakoff SJ
    Transplantation; 1990 Jun; 49(6):1168-70. PubMed ID: 1694317
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive activity, T-cell subset analysis, and acute toxicity of FK-506 in rats.
    Thomson AW; Stephen ME; Woo J; Hasan NU; Whiting PH
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1048-9. PubMed ID: 2468203
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
    Tocci MJ; Matkovich DA; Collier KA; Kwok P; Dumont F; Lin S; Degudicibus S; Siekierka JJ; Chin J; Hutchinson NI
    J Immunol; 1989 Jul; 143(2):718-26. PubMed ID: 2472451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells.
    Chatila T; Wood N; Parsonnet J; Geha RS
    J Immunol; 1988 Feb; 140(4):1250-5. PubMed ID: 2830336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of decrease in calcium ion concentration and pH in mitogen-stimulated thymocytes during treatment with synthetic cycloamidophosphates of glucofuranoses].
    Zinchenko VP; Koroteev MP; Nifant'ev EE; Kochetkov NK
    Dokl Akad Nauk SSSR; 1987; 297(6):1482-5. PubMed ID: 2834162
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
    Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
    [No Abstract]   [Full Text] [Related]  

  • 11. myo-Inositol reverses Li+-induced inhibition of phosphoinositide turnover and ornithine decarboxylase induction during early lymphocyte activation.
    Mustelin T; Pösö H; Iivanainen A; Andersson LC
    Eur J Immunol; 1986 Jul; 16(7):859-61. PubMed ID: 3013648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.
    Zeevi A; Duquesnoy R; Eiras G; Rabinowich H; Todo S; Makowka L; Starzl TE
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):40-4. PubMed ID: 2445073
    [No Abstract]   [Full Text] [Related]  

  • 13. Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats.
    Woo J; Ross CS; Milton JI; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1642-4. PubMed ID: 1697112
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine does not inhibit the early transducing signals generated by the activation of human thymocytes.
    Schleuning M; Duggan A; Reem GH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):63-8. PubMed ID: 3259043
    [No Abstract]   [Full Text] [Related]  

  • 15. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytomitogen induced changes in levels of inositol phosphates in the bovine lymphocytes.
    Dhingra JB; Verma NK; Behl R; Prasad SK; Ahlawat SP
    Indian J Biochem Biophys; 2005 Jun; 42(3):173-7. PubMed ID: 23923560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro.
    Beck Y; Akiyama N
    Transplant Proc; 1989 Jun; 21(3):3464-7. PubMed ID: 2472695
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 19. Signals involved in T cell activation. I. Phorbol esters enhance responsiveness but cannot replace intact accessory cells in the induction of mitogen-stimulated T cell proliferation.
    Davis L; Lipsky PE
    J Immunol; 1985 Nov; 135(5):2946-52. PubMed ID: 3876369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction. Immunosuppressants at work.
    DeFranco AL
    Nature; 1991 Aug; 352(6338):754-5. PubMed ID: 1715515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.